Literature DB >> 27320426

Mechanical strategies to enhance myocardial salvage during primary percutaneous coronary intervention in patients with STEMI.

Gjin Ndrepepa1, Adnan Kastrati.   

Abstract

Primary percutaneous coronary intervention (PPCI) has become the mainstay of reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Despite timely reperfusion by PPCI and restoration of epicardial blood flow in up to 95% of patients, tissue reperfusion remains suboptimal in a sizeable proportion of patients with STEMI. Over the years mechanical and pharmacological strategies to enhance myocardial salvage during PPCI have been developed and used in patients with STEMI. The most common mechanical strategies used in the setting of PPCI include: coronary stenting, direct stenting, mesh-covered stents, self-expanding stents, deferred stenting, thrombectomy, distal protection devices, intra-aortic balloon pumping, left ventricular assist devices and ischaemic conditioning. These strategies are thought to enhance myocardial salvage via improving acute procedural success, attenuation of distal embolisation, microvascular obstruction and reperfusion injury, and providing haemodynamic support. Coronary (direct) stenting is almost the default approach of reperfusion during PPCI procedures. Evidence on the use of mesh-covered stents, self-expanding stents, deferred stenting or left ventricular assist devices is scant and their use in the setting of PPCI remains limited. Mechanical thrombectomy, distal protection devices or routine intra-aortic balloon counterpulsation seem to offer no clinical benefit when used in the setting of PPCI. Although manual aspiration may improve indices of tissue reperfusion, recent research showed no clinical benefit of routine use of this strategy in patients with STEMI undergoing PPCI. Ischaemic conditioning, although promising, remains at an investigational stage and needs further research.

Entities:  

Mesh:

Year:  2016        PMID: 27320426     DOI: 10.4244/EIJV12I3A52

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

1.  Hypothermia therapy for the treatment of acute myocardial infarction: A protocol for systematic review and meta-analysis.

Authors:  Fen Jiang; Defei Zeng; Kongyu Xing; Xiaoli Yang
Journal:  Medicine (Baltimore)       Date:  2021-09-24       Impact factor: 1.817

2.  CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018.

Authors:  Yukio Ozaki; Yuki Katagiri; Yoshinobu Onuma; Tetsuya Amano; Takashi Muramatsu; Ken Kozuma; Satoru Otsuji; Takafumi Ueno; Nobuo Shiode; Kazuya Kawai; Nobuhiro Tanaka; Kinzo Ueda; Takashi Akasaka; Keiichi Igarashi Hanaoka; Shiro Uemura; Hirotaka Oda; Yoshiaki Katahira; Kazushige Kadota; Eisho Kyo; Katsuhiko Sato; Tadaya Sato; Junya Shite; Koichi Nakao; Masami Nishino; Yutaka Hikichi; Junko Honye; Tetsuo Matsubara; Sumio Mizuno; Toshiya Muramatsu; Taku Inohara; Shun Kohsaka; Ichiro Michishita; Hiroyoshi Yokoi; Patrick W Serruys; Yuji Ikari; Masato Nakamura
Journal:  Cardiovasc Interv Ther       Date:  2018-03-29

3.  Mechanical and Pharmacological Revascularization Strategies for Prevention of Microvascular Dysfunction in ST-Segment Elevation Myocardial Infarction: Analysis from Index of Microcirculatory Resistance Registry Data.

Authors:  Ji-Hun Jang; Man-Jong Lee; Kyu-Yong Ko; Jin-Hee Park; Yong-Soo Baek; Kwon Sung-Woo; Sung-Hee Shin; Seong-Ill Woo; Dae-Hyeok Kim; Young Ju Suh; Jun Kwan; Sang-Don Park
Journal:  J Interv Cardiol       Date:  2020-07-09       Impact factor: 2.279

4.  Aspiration Thrombectomy in Patients with Acute Myocardial Infarction-5-Year Analysis Based on a Large National Registry (ORPKI).

Authors:  Rafał Januszek; Zbigniew Siudak; Krzysztof P Malinowski; Roman Wojdyła; Piotr Mika; Wojciech Wańha; Tomasz Kameczura; Andrzej Surdacki; Wojciech Wojakowski; Jacek Legutko; Stanisław Bartuś
Journal:  J Clin Med       Date:  2020-11-09       Impact factor: 4.241

Review 5.  CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022.

Authors:  Yukio Ozaki; Hironori Hara; Yoshinobu Onuma; Yuki Katagiri; Tetsuya Amano; Yoshio Kobayashi; Takashi Muramatsu; Hideki Ishii; Ken Kozuma; Nobuhiro Tanaka; Hitoshi Matsuo; Shiro Uemura; Kazushige Kadota; Yutaka Hikichi; Kenichi Tsujita; Junya Ako; Yoshihisa Nakagawa; Yoshihiro Morino; Ichiro Hamanaka; Nobuo Shiode; Junya Shite; Junko Honye; Tetsuo Matsubara; Kazuya Kawai; Yasumi Igarashi; Atsunori Okamura; Takayuki Ogawa; Yoshisato Shibata; Takafumi Tsuji; Junji Yajima; Kaoru Iwabuchi; Nobuo Komatsu; Teruyasu Sugano; Masaru Yamaki; Shinichiro Yamada; Hiroaki Hirase; Yuusuke Miyashita; Fuminobu Yoshimachi; Masakazu Kobayashi; Jiro Aoki; Hirotaka Oda; Yoshiaki Katahira; Kinzo Ueda; Masami Nishino; Koichi Nakao; Ichiro Michishita; Takafumi Ueno; Taku Inohara; Shun Kohsaka; Tevfik F Ismail; Patrick W Serruys; Masato Nakamura; Hiroyoshi Yokoi; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2022-01-12

6.  Angiographically Based Direct Implantation of the Bioresorbable Vascular Scaffold in Non-ST Segment Elevation Acute Coronary Syndrome: Feasibility and Outcome.

Authors:  Mahmoud Khaled Nour; Hany Tawfik Fathelbab; Ahmad Hosam Mwafy; Mohamad Ashraf Shawky; Santiago Jesús Camacho Freire; Javier León Jiménez; Jessica Roa Garrido; Antonio Enrique Gómez Menchero; Rosa Cardenal Piris; José Francisco Díaz Fernández; Samir ELhadidy Tawfik
Journal:  Open Access Maced J Med Sci       Date:  2019-08-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.